Plasma netrin-1 is a diagnostic biomarker of human cancers

Reference

• Arakawa H. (2004). Netrin-1 and its receptors in tumorigenesis. Nat Rev Cancer 4:978–987.
   PubMed Web of Science ®Google Scholar
• Barallobre MJ, Pascual M, Del Rí,o JA, Soriano E. (2005). The Netrin family of guidance factors: emphasis on Netrin-1 signalling. Brain Res Brain Res Rev 49:22–47.
   PubMedGoogle Scholar
• Bernet A, Mazelin L, Coissieux MM, Gadot N, Ackerman SL, Scoazec JY, Mehlen P. (2007). Inactivation of the UNC5C Netrin-1 receptor is associated with tumor progression in colorectal malignancies. Gastroenterology 133:1840–1848.
   PubMed Web of Science ®Google Scholar
• Bernet A, Fitamant J. (2008). Netrin-1 and its receptors in tumour growth promotion. Expert Opin Ther Targets 12:995–1007.
   PubMed Web of Science ®Google Scholar
• Reeves WB, Kwon O, Ramesh G. (2008). Netrin-1 and kidney injury. II. Netrin-1 is an early biomarker of acute kidney injury. Am J Physiol Renal Physiol 294:F731–F738.
   PubMed Web of Science ®Google Scholar
• Cho WC. (2007). Contribution of oncoproteomics to cancer biomarker discovery. Mol Cancer 6:25.
   PubMed Web of Science ®Google Scholar
• Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr. (1999). Rising incidence of renal cell cancer in the United States. Jama 281:1628–1631.
   Google Scholar
• Delloye-Bourgeois C, Fitamant J, Paradisi A, Cappellen D, Douc-Rasy S, Raquin MA, Stupack D, Nakagawara A, Rousseau R, Combaret V, Puisieux A, Valteau-Couanet D, Bénard J, Bernet A, Mehlen P. (2009). Netrin-1 acts as a survival factor for aggressive neuroblastoma. J Exp Med 206:833–847.
   PubMed Web of Science ®Google Scholar
• Delloye-Bourgeois C, Brambilla E, Coissieux MM, Guenebeaud C, Pedeux R, Firlej V, Cabon F, Brambilla C, Mehlen P, Bernet A. (2009). Interference with netrin-1 and tumor cell death in non-small cell lung cancer. J Natl Cancer Inst 101:237–247.
   PubMed Web of Science ®Google Scholar
• Dumartin L, Quemener C, Laklai H, Herbert J, Bicknell R, Bousquet C, Pyronnet S, Castronovo V, Schilling MK, Bikfalvi A, Hagedorn M. (2010). Netrin-1 mediates early events in pancreatic adenocarcinoma progression, acting on tumor and endothelial cells. Gastroenterology 138:1595–606, 1606.e1.
   Google Scholar
• Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. (2007). Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581–592.
   PubMed Web of Science ®Google Scholar
• Fitamant J, Guenebeaud C, Coissieux MM, Guix C, Treilleux I, Scoazec JY, Bachelot T, Bernet A, Mehlen P. (2008). Netrin-1 expression confers a selective advantage for tumor cell survival in metastatic breast cancer. Proc Natl Acad Sci USA 105:4850–4855.
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. (2006). Cancer statistics, 2006. CA Cancer J Clin 56:106–130.
   PubMed Web of Science ®Google Scholar
• Kaufmann S, Kuphal S, Schubert T, Bosserhoff AK. (2009). Functional implication of Netrin expression in malignant melanoma. Cell Oncol 31:415–422.
   Google Scholar
• Link BC, Reichelt U, Schreiber M, Kaifi JT, Wachowiak R, Bogoevski D, Bubenheim M, Cataldegirmen G, Gawad KA, Issa R, Koops S, Izbicki JR, Yekebas EF. (2007). Prognostic implications of netrin-1 expression and its receptors in patients with adenocarcinoma of the pancreas. Ann Surg Oncol 14:2591–2599.
   PubMed Web of Science ®Google Scholar
• Llambi F, Lourenço FC, Gozuacik D, Guix C, Pays L, Del Rio G, Kimchi A, Mehlen P. (2005). The dependence receptor UNC5H2 mediates apoptosis through DAP-kinase. Embo J 24:1192–1201.
   PubMed Web of Science ®Google Scholar
• Llambi F, Causeret F, Bloch-Gallego E, Mehlen P. (2001). Netrin-1 acts as a survival factor via its receptors UNC5H and DCC. Embo J 20:2715–2722.
   PubMed Web of Science ®Google Scholar
• Ly NP, Komatsuzaki K, Fraser IP, Tseng AA, Prodhan P, Moore KJ, Kinane TB. (2005). Netrin-1 inhibits leukocyte migration in vitro and in vivo. Proc Natl Acad Sci USA 102:14729–14734.
   PubMed Web of Science ®Google Scholar
• Mehlen P, Guenebeaud C. (2010). Netrin-1 and its dependence receptors as original targets for cancer therapy. Curr Opin Oncol 22:46–54.
   PubMed Web of Science ®Google Scholar
• Mirakaj V, Thix CA, Laucher S, Mielke C, Morote-Garcia JC, Schmit MA, Henes J, Unertl KE, Köhler D, Rosenberger P. (2010). Netrin-1 dampens Pulmonary Inflammation during Acute Lung Injury. Am J Respir Crit Care Med 200905–0717OC.
   Google Scholar
• Navankasattusas S, Whitehead KJ, Suli A, Sorensen LK, Lim AH, Zhao J, Park KW, Wythe JD, Thomas KR, Chien CB, Li DY. (2008). The netrin receptor UNC5B promotes angiogenesis in specific vascular beds. Development 135:659–667.
   PubMed Web of Science ®Google Scholar
• Nguyen A, Cai H. (2006). Netrin-1 induces angiogenesis via a DCC-dependent ERK1/2-eNOS feed-forward mechanism. Proc Natl Acad Sci USA 103:6530–6535.
   PubMed Web of Science ®Google Scholar
• Paradisi A, Maisse C, Coissieux MM, Gadot N, Lépinasse F, Delloye-Bourgeois C, Delcros JG, Svrcek M, Neufert C, Fléjou JF, Scoazec JY, Mehlen P. (2009). Netrin-1 up-regulation in inflammatory bowel diseases is required for colorectal cancer progression. Proc Natl Acad Sci USA 106:17146–17151.
   PubMed Web of Science ®Google Scholar
• Rabinovitz I, Mercurio AM. (1997). The integrin alpha6beta4 functions in carcinoma cell migration on laminin-1 by mediating the formation and stabilization of actin-containing motility structures. J Cell Biol 139:1873–1884.
   PubMedGoogle Scholar
• Ramesh G, Krawczeski CD, Woo JG, Wang Y, Devarajan P. (2010). Urinary netrin-1 is an early predictive biomarker of acute kidney injury after cardiac surgery. Clin J Am Soc Nephrol 5:395–401.
   PubMed Web of Science ®Google Scholar
• Rosenberger P, Schwab JM, Mirakaj V, Masekowsky E, Mager A, Morote-Garcia JC, Unertl K, Eltzschig HK. (2009). Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat Immunol 10:195–202.
   PubMed Web of Science ®Google Scholar
• Stanco A, Szekeres C, Patel N, Rao S, Campbell K, Kreidberg JA, Polleux F, Anton ES. (2009). Netrin-1-alpha3beta1 integrin interactions regulate the migration of interneurons through the cortical marginal zone. Proc Natl Acad Sci USA 106:7595–7600.
   PubMed Web of Science ®Google Scholar
• Sturgeon CM, Lai LC, Duffy MJ. (2009). Serum tumour markers: how to order and interpret them. Bmj 339:b3527.
   Google Scholar
• Wang W, Reeves WB, Ramesh G. (2008). Netrin-1 and kidney injury. I. Netrin-1 protects against ischemia-reperfusion injury of the kidney. Am J Physiol Renal Physiol 294:F739–F747.
   PubMed Web of Science ®Google Scholar
• Wilson BD, Ii M, Park KW, Suli A, Sorensen LK, Larrieu-Lahargue F, Urness LD, Suh W, Asai J, Kock GA, Thorne T, Silver M, Thomas KR, Chien CB, Losordo DW, Li DY. (2006). Netrins promote developmental and therapeutic angiogenesis. Science 313:640–644.
   PubMed Web of Science ®Google Scholar
• Yang Y, Zou L, Wang Y, Xu KS, Zhang JX, Zhang JH. (2007). Axon Guidance Cue Netrin-1 has Dual Function in Angiogenesis. Cancer Biol Ther 6:743–748.
   PubMed Web of Science ®Google Scholar
• Yebra M, Montgomery AM, Diaferia GR, Kaido T, Silletti S, Perez B, Just ML, Hildbrand S, Hurford R, Florkiewicz E, Tessier-Lavigne M, Cirulli V. (2003). Recognition of the neural chemoattractant Netrin-1 by integrins alpha6beta4 and alpha3beta1 regulates epithelial cell adhesion and migration. Dev Cell 5:695–707.
   PubMed Web of Science ®Google Scholar